A Saudi CMA case against board and audit committee members over premature revenue recognition — and why the Egyptian affiliate was not named in the decision.
This matter concerns Middle East Healthcare Company (Saudi German Health), listed on the Saudi Exchange — not a general accusation against every Saudi German hospital in every country.
The story from the beginning
Between 2018 and Q3 2021, a serious accounting issue appeared in the company's financial statements relating to revenue recognition. The Saudi Capital Market Authority stated that a number of board and audit committee members manipulated the financial statements by recognizing aggregate unearned revenues of SAR 358,044,138 despite knowing that collectability was weak.
In simple terms: revenues were recorded as if they were due and collectible, while collection probability was weak. The statements therefore painted a better picture than reality — revenues, assets and book value appeared higher than they should. The Authority described this as creating an incorrect and misleading impression of the company's book value.
The case ended with a final decision by the Appeal Committee for the Resolution of Securities Disputes against 11 violators from the board and audit committee, with combined fines of around SAR 18 million, and temporary bans from working at CMA-supervised entities for some individuals.
Where does the audit committee come in?
In any listed company, the audit committee reviews financial statements, oversees reporting integrity and engages with the external auditor. In this case, the conviction was not limited to board members — it also included audit committee members, because the Authority considered they knew collectability was weak and recognition still proceeded.
Was the external auditor convicted?
According to the published official statement, the CMA did not announce a conviction of the external auditor in this decision. The decision focused on board and audit committee members and did not mention a penalty against an external audit firm. Professionally, it is incorrect to say the external auditor was "convicted" in this case unless a separate official decision says so.
What is known for part of the period: the 2020 report notes KPMG Al Fozan & Partners as auditor with no qualifications on the 2020 statements; the 2021 report notes Ernst & Young as external auditor with no remarks on the year ended 31 December 2021.
Was the Egyptian affiliate involved?
Based on available sources, the CMA decision does not state that the Egyptian company or Saudi German hospitals in Egypt were party to the manipulation. The decision specifically addresses the financial statements of the Saudi listed company for 2018–2021.
There are commercial and management links between the Saudi entity and certain Egypt projects — for example, management oversight arrangements and related-party ownership structures — but those links alone do not prove involvement in the Saudi listing violation.
Professional takeaway
The core issue was revenue inflation inside the Saudi listed company. Official conviction targeted board and audit committee members. There is no official evidence, in the sources reviewed, of Egyptian-entity involvement or a public naming of the Egyptian company's statutory auditor. The decisive documents for Egypt would be the local company's latest financial statements or the general assembly minutes appointing its auditor.